Home › NDC Lookup › RxCUI directory › RxCUI 1102273

Rilpivirine 25 MG Oral Tablet — RxCUI 1102273

RxNorm drug concept · Semantic clinical drug
RxCUI 1102273 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1102273
Official nameRilpivirine 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asrilpivirine 25 MG (rilpivirine hydrochloride 27.5 MG) Oral Tablet
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)3,855 prescriptions · 23 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Rilpivirine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Rilpivirine is one piece of your HIV treatment — it blocks a specific enzyme the virus uses to copy itself. But HIV is smart and can develop resistance if only one medicine is used...
  • What exactly is rilpivirine and why do I have to take it with other HIV medicines?
  • It really does matter. When rilpivirine is taken without food, your body absorbs about 40% less of the medicine — and if levels in your blood fall too low, the virus can start repl...
  • Why is it so important to take this with food? Can't I just take it whenever?
📖 Read our full Rilpivirine guide →

🕸️ Concept Web — How Rilpivirine 25 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Rilpivirine 25 MG Oral Tablet RxCUI 1102273

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Rilpivirine 1102270
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Edurant 1102274
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Rilpivirine Oral Tablet 1102272
    • Rilpivirine Oral Product 1165469
    • Rilpivirine Pill 1165470
    • Rilpivirine Oral Tablet [Edurant] 1102276
    • Edurant Oral Product 1173201
    • Edurant Pill 1173202
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Rilpivirine 25 MG SCDC · 1102271
  • Rilpivirine Oral Tablet SCDF · 1102272
  • Rilpivirine Oral Product SCDG · 1165469
  • Rilpivirine Pill SCDG · 1165470

Brand-Name Concepts

  • Rilpivirine 25 MG Oral Tablet [Edurant] SBD · 1102277
  • Rilpivirine 25 MG [Edurant] SBDC · 1102275
  • Rilpivirine Oral Tablet [Edurant] SBDF · 1102276
  • Edurant Oral Product SBDG · 1173201
  • Edurant Pill SBDG · 1173202
  • Edurant BN · 1102274

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 1102273 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59676-0278-01 30 TABLET, FILM COATED in 1 BOTTLE (59676-278-01) EDURANT Janssen Products, LP 2011-05-20
59676-0280-90 9 BLISTER PACK in 1 CARTON (59676-280-90) / 10 TABLET, FOR... EDURANT PED Janssen Products, LP 2024-03-15
70069-0848-30 30 TABLET, FILM COATED in 1 BOTTLE (70069-848-30) Rilpivirine Somerset Therapeutics, LLC 2026-01-30
Observed labelers: Janssen Products, LP (2) · Somerset Therapeutics, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.